Location History:
- Cheshire, GB (2005)
- Macclesfield, GB (2005 - 2017)
Company Filing History:
Years Active: 2005-2017
Title: The Innovative Contributions of Andrew Mortlock
Introduction
Andrew Mortlock is a prominent inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative methods and compounds that have therapeutic applications.
Latest Patents
Among his latest patents are methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide. This patent involves quinazoline derivatives of formula (I), where A is a 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms. Additionally, he has patented phosphonoxy quinazoline derivatives and their pharmaceutical use, which also includes quinazoline derivatives of formula (I) with similar structural characteristics.
Career Highlights
Andrew Mortlock is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on the development of innovative therapies that address various medical needs.
Collaborations
Throughout his career, Mortlock has collaborated with notable colleagues, including Frederic H Jung and Nicola Murdoch Heron. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Andrew Mortlock's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic methods and compounds.